CAAS [CHINA AUTOMOTIVE SYSTEMS] S-3/A:

[] [CHINA AUTOMOTIVE SYSTEMS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [ — ], 20[ — ] Senior Debt Securities Table of Contents (1) Page ARTICLE 1 DEFINITIONS 5 Section 1.01 Definitions of Terms 5 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 8 Section 2.01 Designation and Terms of Securities 8 Section 2.02 Form of] [CHINA AUTOMOTIVE SYSTEMS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [ — ], 20[ — ] Subordinated Debt Securities Table of Contents (1) Page ARTICLE 1 DEFINITIONS 5 Section 1.01 Definitions of Terms 5 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 5 Section 2.01 Designation and Terms of Securities 8 Section 2.02 Form of] [May 22, 2015 China Automotive Systems, Inc. Re: China Automotive Systems, Inc. Registration Statement on Form S-3 for Primary Sale of Shares of Common Stock by the Company and Resale of Shares of Common Stock by the Selling Shareholders with an aggregate public offering price of up to US$200,000,000 Ladies and Gentlemen: Company Registration Statement Act Commission We have acted] [China Automotive Systems, Inc. Computation of Ratio of Earnings to Fixed Charges (Dollars in thousands) Three Fiscal Year Ended December 31, 2015 2014 2013 2012 2011 2010 Earnings: Income before income taxes and equity in earnings of affiliated companies $ 9,736 $ 46,081 $ 38,241 $ 30,069 $ 52,099 $ 71,416 Add (deduct): Fixed charges 637 2,549 2,298 3,464 5,393] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Amendment No. 1 to the Registration Statement on Form S-3 of our report dated March 26, 2015, relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in China Automotive Systems, Inc.’s Annual Report on Form]

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES RECEIPT OF Xi’an, China,

[SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES RECEIPT OF Xi’an, China, May 22, 2015 – Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that the Company received a notification from the Nasdaq Stock Market (“Nasdaq”) informing the Company that since it had not filed its Quarterly Report on Form 10-Q for] [By Electronic Delivery to: bing@skystarbio-pharmaceutical.com; aorudjev@schiffhardin.com; scramer@skystarbio-pharmaceutical.com May 21, 2015 Mr. Bing Mei Chief Financial Officer Skystar Bio-Pharmaceutical Company 4/F Building B, Chuangye Square, No. 48 Keji Road Gaoxin District, Xi’an Shaanxi Province, P.R. China Re: Skystar Bio-Pharmaceutical Company (the “Company”) Nasdaq Symbol: SKBI Dear Mr. Mei: As you know, since we have not received the Company’s Form 10-Q for] []

By | 2016-03-27T15:19:05+00:00 May 22nd, 2015|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

ATAI [ATA] 6-K: (Original Filing)

[ATA Announces Potential Plans to List Testing Services Business on China’s New Third Board Beijing, China, May 22 , 2015 — ATA Inc. (“ATA” or the “Company”, Nasdaq: ATAI) Mr. Kevin Ma, ATA’s Chairman and CEO, stated, “Over the years, ATA’s business has evolved and expanded to serve a growing test-taker and client base. As we continue our efforts in] [FORM 6-K ATA INC. 1/F East Gate, Building No.2, Jian Wai Soho, No.39 Dong San Huan Zhong Road, Chao Yang District, Beijing 100022, China Form 20-F x Form 40-F o o o Yes o No x 82- N/A]

By | 2016-03-25T12:54:46+00:00 May 22nd, 2015|Categories: ATAI, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

LONG [eLong] SC 13D/A: (Original Filing)

[EXECUTION VERSION SHARE PURCHASE AGREEMENT by and among EXPEDIA, INC., EXPEDIA ASIA PACIFIC – ALPHA LIMITED, CTRIP.COM INTERNATIONAL, LTD., C-TRAVEL INTERNATIONAL LIMITED, LUXURIANT HOLDINGS LIMITED, KEYSTONE LODGING HOLDINGS LIMITED, and PLATENO GROUP LIMITED Dated as of May 22, 2015 TABLE OF CONTENTS Page Article I DEFINITIONS 1 Section 1.1 Defined Terms 1 Section 1.2 Interpretation and Rules of Construction 7] [Expedia Announces eLong Transaction EXPE LONG CTRP BELLEVUE, Wash., May 22, 2015 /PRNewswire/ — Expedia, Inc. (NASDAQ: In addition, Expedia and Ctrip have agreed to cooperate with each other to allow their respective customers to benefit from certain travel product offerings for specified geographic markets. The transaction closed on May 22, 2015. About Expedia, Inc. EXPE Expedia, Inc. (NASDAQ: •] [1 NAMES OF REPORTING PERSONS: Expedia Asia Pacific – Alpha Limited I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) ¨ (b) x 3 SEC USE ONLY: 4]

By | 2016-03-28T09:08:30+00:00 May 22nd, 2015|Categories: Chinese Stocks, LONG, SEC Original|Tags: , , , , , |0 Comments

SFUN [SouFun] 6-K: (Original Filing)

[News Release SouFun Announces First Quarter 2015 Results BEIJING, China, May 20, 2015 – SouFun Holdings Limited (NYSE: SFUN) (“SouFun”), the leading real estate Internet portal in China, announced today its unaudited financial results for the three months ended March 31, 2015. First Quarter 2015 Highlights n Total Revenue n Operating income Non-GAAP operating income n Net income attributable to] []

ATAI [ATA] 6-K: ATA Announces Potential Plans to List Testing Services

[ATA Announces Potential Plans to List Testing Services Business on China’s New Third Board Beijing, China, May 22 , 2015 — ATA Inc. (“ATA” or the “Company”, Nasdaq: ATAI) Mr. Kevin Ma, ATA’s Chairman and CEO, stated, “Over the years, ATA’s business has evolved and expanded to serve a growing test-taker and client base. As we continue our efforts in] [FORM 6-K ATA INC. 1/F East Gate, Building No.2, Jian Wai Soho, No.39 Dong San Huan Zhong Road, Chao Yang District, Beijing 100022, China Form 20-F x Form 40-F o o o Yes o No x 82- N/A]

By | 2016-03-25T12:55:49+00:00 May 22nd, 2015|Categories: ATAI, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar